STOCK TITAN

[6-K] Sanofi Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Sanofi furnished a Form 6-K noting a press release titled “Sanofi successfully prices USD 3 billion of bond issue.” The filing indicates the company priced a USD 3 billion bond and includes the press release as Exhibit 99.1.

The press release is dated October 28, 2025, and is incorporated by reference in the submission.

Sanofi ha fornito una Form 6-K con una notifica riguardante un comunicato stampa intitolato “Sanofi fissa con successo un'emissione obbligazionaria da 3 miliardi di USD.” Il filing indica che l'azienda ha collocato un'obbligazione da USD 3 miliardi e incorpora il comunicato come Allegato 99.1.

Il comunicato è datato 28 ottobre 2025 ed è incorporato per riferimento nella presentazione.

Sanofi presentó un Formulario 6-K que señala un comunicado de prensa titulado “Sanofi fija con éxito una emisión de bonos por 3 miles de millones de USD.” El expediente indica que la empresa colocó un bono por USD 3,000 millones y adjunta el comunicado de prensa como Anexo 99.1.

El comunicado está fechado el 28 de octubre de 2025 y está incorporado por referencia en la presentación.

Sanofi는 보도자료 제목이 “Sanofi가 미화 30억 달러 채권 발행을 성공적으로 가격 책정했다”인 Form 6-K를 제출했습니다. 제출 문서는 회사가 미화 30억 달러의 채권을 가격 책정했다는 것을 표시하며, 보도자료를 부록 99.1로 포함합니다.

보도자료의 날짜는 2025년 10월 28일이며, 제출서에 참조로 포함되어 있습니다.

Sanofi a fourni un formulaire 6-K indiquant un communiqué de presse intitulé « Sanofi fixe avec succès une émission obligataire de 3 milliards de dollars ». Le dépôt indique que l'entreprise a placé une obligation de 3 milliards USD et inclut le communiqué de presse en tant qu'Annexe 99.1.

Le communiqué daté du 28 octobre 2025 est incorporé par référence dans la soumission.

Sanofi lieferte ein Form 6-K ein, das eine Pressemitteilung mit dem Titel „Sanofi setzt erfolgreich eine Anleiheemission über 3 Milliarden USD fest“ vermerkt. Das Einreichung zeigt, dass das Unternehmen eine USD 3 Milliarden Anleihe platziert hat und die Pressemitteilung als Anhang 99.1 enthält.

Die Pressemitteilung ist auf den 28. Oktober 2025 datiert und wird in der Einreichung als Referenz aufgenommen.

سانوفي قد قدمت نموذج 6-K يلاحظ بياناً صحفياً بعنوان "سانوفي تسعّر بنجاح إصدار سندات بقيمة 3 مليار دولار." يشير الملف إلى أن الشركة قد قدّرت سنداً بقيمة 3 مليارات دولار ويشمل البيان الصحفي كمرفق 99.1.

البيان الصحفي مؤرّخ في 28 أكتوبر 2025 ومُدرج بالرجوع ضمن التقديم.

Positive
  • None.
Negative
  • None.

Insights

Neutral financing disclosure of a USD 3 billion bond.

Sanofi reported that it priced a USD 3 billion bond, with the associated details contained in a press release incorporated as Exhibit 99.1. The 6-K serves as a formal notice of this financing activity.

As presented, this is an administrative update confirming the transaction amount and the availability of the press release for specifics. Any evaluation of cost of capital, maturity profile, or structure would be based on the referenced exhibit.

Sanofi ha fornito una Form 6-K con una notifica riguardante un comunicato stampa intitolato “Sanofi fissa con successo un'emissione obbligazionaria da 3 miliardi di USD.” Il filing indica che l'azienda ha collocato un'obbligazione da USD 3 miliardi e incorpora il comunicato come Allegato 99.1.

Il comunicato è datato 28 ottobre 2025 ed è incorporato per riferimento nella presentazione.

Sanofi presentó un Formulario 6-K que señala un comunicado de prensa titulado “Sanofi fija con éxito una emisión de bonos por 3 miles de millones de USD.” El expediente indica que la empresa colocó un bono por USD 3,000 millones y adjunta el comunicado de prensa como Anexo 99.1.

El comunicado está fechado el 28 de octubre de 2025 y está incorporado por referencia en la presentación.

Sanofi는 보도자료 제목이 “Sanofi가 미화 30억 달러 채권 발행을 성공적으로 가격 책정했다”인 Form 6-K를 제출했습니다. 제출 문서는 회사가 미화 30억 달러의 채권을 가격 책정했다는 것을 표시하며, 보도자료를 부록 99.1로 포함합니다.

보도자료의 날짜는 2025년 10월 28일이며, 제출서에 참조로 포함되어 있습니다.

Sanofi a fourni un formulaire 6-K indiquant un communiqué de presse intitulé « Sanofi fixe avec succès une émission obligataire de 3 milliards de dollars ». Le dépôt indique que l'entreprise a placé une obligation de 3 milliards USD et inclut le communiqué de presse en tant qu'Annexe 99.1.

Le communiqué daté du 28 octobre 2025 est incorporé par référence dans la soumission.

Sanofi lieferte ein Form 6-K ein, das eine Pressemitteilung mit dem Titel „Sanofi setzt erfolgreich eine Anleiheemission über 3 Milliarden USD fest“ vermerkt. Das Einreichung zeigt, dass das Unternehmen eine USD 3 Milliarden Anleihe platziert hat und die Pressemitteilung als Anhang 99.1 enthält.

Die Pressemitteilung ist auf den 28. Oktober 2025 datiert und wird in der Einreichung als Referenz aufgenommen.

سانوفي قد قدمت نموذج 6-K يلاحظ بياناً صحفياً بعنوان "سانوفي تسعّر بنجاح إصدار سندات بقيمة 3 مليار دولار." يشير الملف إلى أن الشركة قد قدّرت سنداً بقيمة 3 مليارات دولار ويشمل البيان الصحفي كمرفق 99.1.

البيان الصحفي مؤرّخ في 28 أكتوبر 2025 ومُدرج بالرجوع ضمن التقديم.

赛诺菲提交了一份6-K表格,提及题为“赛诺菲成功定价30亿美元债券发行”的新闻稿。该 filing 表明公司定价了一个30亿美元的债券,并将新闻稿作为附件99.1纳入。

新闻稿日期为2025年10月28日,并在提交中通过引用纳入。

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the month of October 2025

Commission File Number: 001-31368

SANOFI

(Translation of registrant’s name into English)

46, avenue de la Grande Armée, 75017 Paris, FRANCE

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒  Form 40-F

 

1


In October 2025, Sanofi published the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.

Exhibit Index

 

Exhibit No.

  

Description

Exhibit 99.1    Press Release dated October 28, 2025: Sanofi successfully prices USD 3 billion of bond issue

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: October 28, 2025       SANOFI
    By  

/s/ Alexandra Roger

      Name: Alexandra Roger
      Title: Head of Legal Corporate & Finance

 

3

FAQ

What did Sanofi (SNY) report in this 6-K?

Sanofi noted a press release titled “Sanofi successfully prices USD 3 billion of bond issue,” incorporated as Exhibit 99.1.

How large is Sanofi’s bond issue mentioned in the filing?

The filing references a bond issue of USD 3 billion.

When is the referenced Sanofi press release dated?

The press release is dated October 28, 2025.

Where can investors find more details on the bond pricing?

Details are contained in Exhibit 99.1, the incorporated press release.

What is the purpose of this Sanofi Form 6-K?

It furnishes notice of the press release and incorporates it by reference into the submission.
Sanofi FR

NASDAQ:SNY

SNY Rankings

SNY Latest News

SNY Latest SEC Filings

SNY Stock Data

125.23B
2.53B
0%
10.28%
0.21%
Drug Manufacturers - General
Healthcare
Link
France
Paris